BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study

NCT03916328 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Bone Loss

Interventions

DRUG: B/F/TAF
DRUG: TDF/3TC/EFV or DTG or NVP
OTHER: DMPA

Sponsor

MU-JHU CARE